Skip to content
value.today

AstraZeneca PLC vs Pfizer Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • AstraZeneca PLC is the larger company by market value: $242.6 B against $170.7 B for Pfizer Inc., 1.4 times as much (market caps of Aug 1, 2026 for AstraZeneca PLC and Oct 30, 2026 for Pfizer Inc.). AstraZeneca PLC's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
  • Pfizer Inc. had more revenue: $62.6 B against $58.7 B for AstraZeneca PLC, both in the year to December 2025.
  • AstraZeneca PLC earned more: net income of $10.2 B against $7.8 B for Pfizer Inc.
  • AstraZeneca PLC keeps more of each dollar of sales: a net margin of 17.4% against 12.4% for Pfizer Inc.
  • AstraZeneca PLC employs more people: 89,900 against 75,000 at Pfizer Inc. Each employee brings in about $653,382 of revenue at AstraZeneca PLC and $834,387 at Pfizer Inc.
  • On price to earnings, Pfizer Inc. trades at 42.3× and AstraZeneca PLC at 23.7×: investors pay more for each dollar of Pfizer Inc.'s profit.
  • AstraZeneca PLC's revenue grew faster in its latest fiscal year: +8.6% against -1.6% for Pfizer Inc.
  • On the Piotroski F-score, a nine-point test of improving finances, AstraZeneca PLC scores 8 and Pfizer Inc. 5.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

045901341792020202120222023202420252026AstraZeneca PLC 179Pfizer Inc. 79

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$25B$51B$76B$101B201720182019202020212022202320242025AstraZeneca PLC $59BPfizer Inc. $63B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAstraZeneca PLC
AZN · #76 in the world
Pfizer Inc.
PFE · #127 in the world
Profile
Country🇬🇧 UK🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded19991849
Size
Market cap$242.6 B$170.7 B
Revenue$58.7 B$62.6 B
Net income$10.2 B▲ best$7.8 B
Employees89,90075,000
Valuation
P/E ratio23.7×42.3×
Price to sales4.1×2.7×
Price to book5.0×2.0×
Free cash flow yield4.8%5.3%▲ best
Profitability
Gross margin81.9%▲ best74.3%
Operating margin23.4%—
Net margin17.4%▲ best12.4%
Return on equity22.9%▲ best8.9%
Return on invested capital17.5%—
Growth
Revenue growth8.6%▲ best-1.6%
Revenue growth, 3 years a year9.8%▲ best-14.8%
Earnings per share growth45.3%▲ best-3.5%
Financial strength
Debt to equity0.5×▲ best0.7×
Interest cover8.1×—
Cash
Free cash flow margin20.0%▲ best14.5%
Shareholder returns
Dividend yield2.0%—
Shareholder yield2.3%—
Strength scores
Piotroski F-score8 of 9▲ best5 of 9
Altman Z-score zonesafe—
Data as ofMarket cap Aug 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, AstraZeneca PLC or Pfizer Inc.?

AstraZeneca PLC is the larger company by market value: $242.6 B against $170.7 B for Pfizer Inc., 1.4 times as much (market caps of Aug 1, 2026 for AstraZeneca PLC and Oct 30, 2026 for Pfizer Inc.). AstraZeneca PLC's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.

Which makes more money, AstraZeneca PLC or Pfizer Inc.?

Pfizer Inc. had more revenue: $62.6 B against $58.7 B for AstraZeneca PLC, both in the year to December 2025. AstraZeneca PLC earned more: net income of $10.2 B against $7.8 B for Pfizer Inc.

Which is more profitable, AstraZeneca PLC or Pfizer Inc.?

AstraZeneca PLC keeps more of each dollar of sales: a net margin of 17.4% against 12.4% for Pfizer Inc.

Which has more employees, AstraZeneca PLC or Pfizer Inc.?

AstraZeneca PLC employs more people: 89,900 against 75,000 at Pfizer Inc. Each employee brings in about $653,382 of revenue at AstraZeneca PLC and $834,387 at Pfizer Inc.

Is AstraZeneca PLC cheaper than Pfizer Inc.?

On price to earnings, Pfizer Inc. trades at 42.3× and AstraZeneca PLC at 23.7×: investors pay more for each dollar of Pfizer Inc.'s profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.

Which is growing faster, AstraZeneca PLC or Pfizer Inc.?

AstraZeneca PLC's revenue grew faster in its latest fiscal year: +8.6% against -1.6% for Pfizer Inc.

Which is financially stronger, AstraZeneca PLC or Pfizer Inc.?

On the Piotroski F-score, a nine-point test of improving finances, AstraZeneca PLC scores 8 and Pfizer Inc. 5.

Sources#

Every figure on this page comes from these, with the date shown next to it.